Phacilitate Leaders World


Jakub  Baran

Jakub Baran

CEO & COO, Famicord Group, Polski Bank Komórek Macierzystych S.A.

2005 - COO and then CEO&COO at The Polish Stem Cell Bank (Famicord Group)

Main achievements:

  • organized 4 rounds of financing (Business Angel in 2006, private placement in 2008, private placement in 2009, venture fund in 2009) and sucessfull IPO of the company at Warsaw Stock Exchange in 2016
  • responsible personally for several successful M&A/joint-venture/investment transactions in: Spain, Romania, Poland, Turkey, Hungary, Sweden and more
  • In 2016 Famicord Group became no 1 family stem cell bank in Europe in terms of revenue, profit and numbers of new collections

2002 – co-founder of The Polish Stem Cell Bank (Famicord Group)

2003-2005 – IBM, sales manager telecommunication sector

1995-2003 – Hewlett-Packard, various technical and sales positions

1990-1995 – Technical University of Warsaw, Faculty of Electronics

MSc and Eng. in Digital Signal Processing

Personally fan of strategic games (Baduk, chess), cross-words and SF literaturę.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman